227 related items for PubMed ID: 17573408
21. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
22. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus.
Jartti T, Lehtinen P, Vanto T, Hartiala J, Vuorinen T, Mäkelä MJ, Ruuskanen O.
Pediatr Infect Dis J; 2006 Jun; 25(6):482-8. PubMed ID: 16732144
[Abstract] [Full Text] [Related]
23. Zinc supplement in reduction of relapses in children with steroid sensitive nephrotic syndrome.
Sherali AR, Moorani KN, Chishty SH, Khan SI.
J Coll Physicians Surg Pak; 2014 Feb; 24(2):110-3. PubMed ID: 24491005
[Abstract] [Full Text] [Related]
24. Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.
Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A.
Clin J Am Soc Nephrol; 2011 Jan; 6(1):63-9. PubMed ID: 20847092
[Abstract] [Full Text] [Related]
25. REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.
Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF.
BMJ Open; 2017 Sep 27; 7(9):e018148. PubMed ID: 28963315
[Abstract] [Full Text] [Related]
26. Levamisole in steroid dependent and frequently relapsing nephrotic syndrome.
Hafeez F, Ahmed TM, Samina U.
J Coll Physicians Surg Pak; 2006 Jan 27; 16(1):35-7. PubMed ID: 16441986
[Abstract] [Full Text] [Related]
27. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT, Yang LY.
J Microbiol Immunol Infect; 2006 Oct 27; 39(5):422-5. PubMed ID: 17066206
[Abstract] [Full Text] [Related]
28. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
Pediatr Nephrol; 2017 Aug 27; 32(8):1363-1367. PubMed ID: 28299461
[Abstract] [Full Text] [Related]
29. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study.
Garg RK, Potluri N, Kar AM, Singh MK, Shukla R, Agrawal A, Verma R.
J Infect; 2006 Jul 27; 53(1):65-9. PubMed ID: 16269179
[Abstract] [Full Text] [Related]
30. [The effect of treatment methods on frequency of relapse in nephrotic syndrome in children].
Goszczyk A, Jung A, Bochniewska V, Straz-Zebrowska E.
Pol Merkur Lekarski; 2000 Sep 27; 9 Suppl 1():25-6. PubMed ID: 11081338
[Abstract] [Full Text] [Related]
31. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
Donaldson D, Sundermann R, Jackson R, Bastani A.
Am J Emerg Med; 2008 Feb 27; 26(2):124-30. PubMed ID: 18272089
[Abstract] [Full Text] [Related]
32. Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections.
Fuller R, Butt H, Noakes PS, Kenyon J, Yam TS, Calder PC.
Nutrition; 2012 Jun 27; 28(6):665-9. PubMed ID: 22465901
[Abstract] [Full Text] [Related]
33. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
Nephrol Dial Transplant; 2009 Oct 27; 24(10):3082-8. PubMed ID: 19465558
[Abstract] [Full Text] [Related]
34. Self treatment with one of three self selected, ultramolecular homeopathic medicines for the prevention of upper respiratory tract infections in children. A double-blind randomized placebo controlled trial.
Steinsbekk A, Bentzen N, Fønnebø V, Lewith G.
Br J Clin Pharmacol; 2005 Apr 27; 59(4):447-55. PubMed ID: 15801940
[Abstract] [Full Text] [Related]
35. Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome.
Ekka BK, Bagga A, Srivastava RN.
Pediatr Nephrol; 1997 Oct 27; 11(5):597-9. PubMed ID: 9323286
[Abstract] [Full Text] [Related]
36. Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome.
Hari P, Bagga A, Mantan M.
Indian Pediatr; 2004 Oct 27; 41(10):993-1000. PubMed ID: 15523124
[Abstract] [Full Text] [Related]
37. [Current aspects of transformation of morphological changes in children with nephrotic syndrome depending on the treatment regimen].
Sharipov AM, Khamzaeva KA.
Urologiia; 2007 Oct 27; (2):68-71. PubMed ID: 17580388
[Abstract] [Full Text] [Related]
38. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
Veltkamp F, Khan DH, Reefman C, Veissi S, van Oers HA, Levtchenko E, Mathôt RAA, Florquin S, van Wijk JAE, Schreuder MF, Haverman L, Bouts AHM.
BMJ Open; 2019 Aug 01; 9(8):e027011. PubMed ID: 31375606
[Abstract] [Full Text] [Related]
39. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr 01; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
40. Concurrent use of cyclophosphamide and prednisolone in childhood nephrotic syndrome in South-East Nigeria; a report of 5 cases.
Obidike EO.
Niger J Clin Pract; 2009 Mar 01; 12(1):108-12. PubMed ID: 19562934
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
